ESPR — Esperion Therapeutics, Inc.
Dividend Grades
vs Healthcare sector| Metric | ESPR | Sector Median |
|---|---|---|
| Dividend Yield | 99.37% | 1.41% |
| Dividend Growth (5Y) | — | 5.87% |
| Payout Ratio | — | 26.6% |
| Consecutive Years Paid | 1 | 15 |
| 1Y Total Return | — | 14.6% |
Grades compare this stock to Healthcare sector peers using percentile ranks. A+ = top 10%, F = bottom 10%. See methodology →
1-Year Growth
N/A
3-Year Growth
N/A
5-Year Growth
N/A
10-Year Growth
N/A
Key Dividend Dates
Next Ex-Date
N/A
Next Payment
N/A
Last Ex-Date
Jul 13, 2026
Last Payment
N/A
Dividend History
| Ex-Date | Amount | Change |
|---|---|---|
| Jul 13, 2026 | $3.1600 | N/A |
Payout Ratio (Earnings)
N/A
FCF Payout Ratio
N/A
Financial Snapshot
| Period | EPS | FCF |
|---|---|---|
| Q1 2026 | $-0.10 | -$27.91M |
| Q1 2025 | $-0.21 | -$22.63M |
| Q2 2025 | $-0.02 | -$31.42M |
| Q3 2025 | $-0.16 | -$4.29M |
Peer Comparison
Compare ESPR:
About this data
Dividend data sourced from Financial Modeling Prep. Prices updated daily after market close.
Payout ratio — trailing 12-month dividends paid / trailing 12-month net income.
Consecutive years — calendar years with a higher total annual dividend than the prior year.
Growth rates — annualized, comparing the most recent full year total to the total N years prior.
For informational purposes only. Not investment advice.
Data as of August 6, 2026. Source: Financial Modeling Prep. Prices and yields updated daily after market close.